Literature DB >> 11987129

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

Sílvia Barceló-Batllori1, Muriel André, Catherine Servis, Nicole Lévy, Osamu Takikawa, Pierre Michetti, Marc Reymond, Emanuela Felley-Bosco.   

Abstract

A role for cytokine regulated proteins in epithelial cells has been suggested in the pathogenesis of inflammatory bowel diseases (IBD). The aim of this study was to identify such cytokine regulated targets using a proteomic functional approach. Protein patterns from (35)S-radiolabeled homogenates of cultured colon epithelial cells were compared before and after exposure to interferon-gamma, interleukin-1beta and interleukin-6. Proteins were separated by two-dimensional polyacrylamide gel electrophoresis. Both autoradiographies and silver stained gels were analyzed. Proteins showing differential expression were identified by tryptic in-gel digestion and mass spectrometry. Metabolism related proteins were also investigated by Western blot analysis. Tryptophanyl-tRNA synthetase, indoleamine-2,3-dioxygenase, heterogeneous nuclear ribonucleoprotein JKTBP, interferon-induced 35kDa protein, proteasome subunit LMP2 and arginosuccinate synthetase were identified as cytokine modulated proteins in vitro. Using purified epithelial cells from patients, overexpression of indoleamine-2,3-dioxygenase, an enzyme involved in tryptophan metabolism, was confirmed in Crohn's disease as well as in ulcerative colitis, as compared to normal mucosa. No such difference was found in diverticulitis. Potentially, this observation opens new avenues in the treatment of IBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11987129     DOI: 10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  34 in total

1.  Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice.

Authors:  Leo R Fitzpatrick; Vineeta Khare; Jeffrey S Small; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 2.  The future of molecular approaches to inflammatory bowel disease.

Authors:  Boyko Kabakchiev; Smita Halder; Mark S Silverberg
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

3.  Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.

Authors:  Nitin K Gupta; Ameet I Thaker; Navya Kanuri; Terrence E Riehl; Christopher W Rowley; William F Stenson; Matthew A Ciorba
Journal:  Inflamm Bowel Dis       Date:  2011-08-05       Impact factor: 5.325

Review 4.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

Review 5.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

6.  Indoleamine 2,3-dioxygenase, tryptophan catabolism, and Mycobacterium avium subsp. paratuberculosis: a model for chronic mycobacterial infections.

Authors:  Karren M Plain; Kumudika de Silva; John Earl; Douglas J Begg; Auriol C Purdie; Richard J Whittington
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

7.  Proteome profiling of spinal cord and dorsal root ganglia in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Xiao-Jun Zhang; Feung Ping Leung; Wendy Wl Hsiao; Shun Tan; Shao Li; Hong-Xi Xu; Joseph Jy Sung; Zhao-Xiang Bian
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 8.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 9.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

Review 10.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.